Journal Articles

Donald and Barbara Zucker School of Medicine
Academic Works

2018

Editorial: Neuro-Immune Interactions in
Inflammation and Autoimmunity
N. Terrando
V. A. Pavlov
Zucker School of Medicine at Hofstra/Northwell

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Medical Molecular Biology Commons
Recommended Citation
Terrando N, Pavlov VA. Editorial: Neuro-Immune Interactions in Inflammation and Autoimmunity. . 2018 Jan 01; 9():Article 3842 [
p.]. Available from: https://academicworks.medicine.hofstra.edu/articles/3842. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.

Editorial
published: 16 April 2018
doi: 10.3389/fimmu.2018.00772

Editorial: Neuro-immune interactions
in inflammation and autoimmunity
Niccolò Terrando1* and Valentin A. Pavlov 2*
Center for Translational Pain Medicine, Department of Anesthesiology, Duke University Medical Center, Durham, NC,
United States, 2 Center for Biomedical Science and Bioelectronic Medicine, The Feinstein Institute for Medical Research,
Northwell Health, Manhasset, NY, United States

1

Keywords: neuro-immune interactions, immunity, inflammation, autoimmunity, cytokines, antibodies

Editorial on the Research Topic
Neuro-Immune Interactions in Inflammation and Autoimmunity

Edited and Reviewed by:
Pietro Ghezzi,
University of Sussex,
United Kingdom
*Correspondence:
Niccolò Terrando
niccolo.terrando@duke.edu;
Valentin A. Pavlov
vpavlov@northwell.edu
Specialty section:
This article was submitted
to Inflammation,
a section of the journal
Frontiers in Immunology
Received: 16 March 2018
Accepted: 28 March 2018
Published: 16 April 2018
Citation:
Terrando N and Pavlov VA (2018)
Editorial: Neuro-Immune Interactions
in Inflammation and Autoimmunity.
Front. Immunol. 9:772.
doi: 10.3389/fimmu.2018.00772

The nervous system plays an important role in the regulation of immunity and inflammation
(1, 2). However, neuronal integrity and brain function may be severely altered in inflammatory and
autoimmune conditions (3–5). Recent studies have characterized neural pathways communicating
peripheral inflammatory signals to the central nervous system (CNS), and brain- and spinal cordderived circuitries controlling various innate and adaptive immune responses and inflammation
(1, 2). A prototypical neural reflex circuit that regulates immunity and inflammation is the vagus
nerve-based “inflammatory reflex” (6). Pharmacological and bioelectronic modulation of neural
cholinergic circuitry in the inflammatory reflex has been successfully explored in preclinical settings of sepsis, arthritis, inflammatory bowel disease, obesity-driven disorders, diabetes, and other
diseases (1). These studies paved the way to successful clinical trials in inflammatory bowel disease,
rheumatoid arthritis, and metabolic syndrome (7–9).
Dysregulated release of cytokines and other inflammatory molecules may have a severe impact on
brain function (10). Brain inflammation (neuroinflammation), imbalances in brain neuronal integrity, neurotransmitter release, and cognitive impairment are characteristic features of perioperative
neurological disorders, sepsis, pain, liver diseases, diabetes, and other conditions characterized by
immune and metabolic dysregulation (3, 11, 12). These findings and the characterization of brainreactive antibodies and neuroprotective cytokines indicated new therapeutic approaches for treating
inflammatory and autoimmune disorders and their neurological complications (4, 13, 14).
The collection of 19 papers on this research topic substantially contributes to improved understanding of neuro-immune communication and its therapeutic relevance. Yuki et al. elaborate on
neuro-immune interactions within the gateway reflexes that regulate the entry of pathogenic CD4+
T lymphocytes in the CNS and neuroinflammation. They also point to the need of further characterization of the functional anatomy of these reflexes that will be of interest for their therapeutic
exploration to alleviate local neuroinflammation in pathological conditions, including multiple
sclerosis. Bonaz et al. review the role of the vagus nerve as a regulator of inflammatory processes
in the gastrointestinal tract. They also elaborate on accumulating experimental evidence indicating
possibilities to use electrical vagus nerve stimulation for therapeutic benefit in inflammatory bowel
disease and other gastrointestinal disorders in preclinical and clinical settings. Innoe et al. outline new
findings related to the neural vagus nerve control of inflammation with a specific focus on the kidney
disease. They also summarize evidence that this neural regulation can be activated by the use of ultrasound and other modalities to alleviate inflammation and acute kidney injury in murine models. The
splenic noradrenergic innervations are implicated in neuroimmunomodulation and are an important
component of the inflammatory reflex through their functional cooperation with the vagus nerve.
Hoover et al. provide insight into the anatomy of noradrenergic neurons in relation to leukocytes in
the human spleen and experimental evidence for a significant splenic noradrenergic neuronal loss
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in patients who died from sepsis. These findings are of interest
for further studies on the neural regulation of inflammatory processes in the spleen in the context of sepsis and other conditions.
Fujii et al. present a thorough review of the cholinergic system,
including choline acetyltransferase, acetylcholinesterase, acetylcholine, and muscarinic and nicotinic acetylcholine receptors in
immune cells, such as macrophages, dendritic cells, and T and B
lymphocytes. They also summarize findings about the functional
role of this non-neuronal cholinergic system in the regulation of
innate and adaptive immune responses. Valdés-Ferrer et al. evaluated the role of pyridostigmine, an acetyl-cholinesterase inhibitor,
in a 16-week proof-of-concept open-label trial in HIV-infected
patients with discordant immune responses. By using this strategy,
the authors harnessed the cholinergic anti-inflammatory pathway
and demonstrated that pyridostigmine can promote recovery of
CD4+ T-cell counts by reducing T cell overactivation. Bosmans
et al. discuss the role of cholinergic signaling, mediated through
nicotinic and muscarinic receptors in the regulation of allergic
inflammation, including barrier function, innate and adaptive
immune responses, and effector cells responses. They also point to
possibilities of exploring cholinergic regulation of type 2 immune
responses in the treatment of allergic diseases.
Mader et al. outline how antibodies associated with autoimmune diseases lead to brain pathology and irreversible damage,
specifically focusing on conditions such as systemic lupus erythematosus and neuromyelitis optica. They summarize some of the
key mechanisms involved in these antibody-mediated pathologies and discuss the urgency to develop more appropriate and less
invasive treatments for antibody-mediated diseases. Foster et al.
outline the latest insights into the molecular mechanisms of the
relationship between sensory neurons and immune cells, which
can be protective, but also maladaptive. They elaborate on the
role of nociceptors (noxious stimulus detecting sensory neurons)
in the regulation of adaptive immunity with a specific focus on
the involvement of nociceptors in the regulation of type 2 adaptive immune responses in airway inflammation. Gunasekaran
et al. report on their discovery that peripheral sensory neurons
of the dorsal root ganglia (DRG) of immunized mice contain
antigen-specific antibodies. The authors use a combination
of molecular genetic analyses, transgenic mice, and adoptive
transfer experiments, to reveal that DRGs do not synthesize
antigen-specific antibodies, but sequester primarily IgG1 subtype
antibodies released by antibody-secreting plasma cells. In the
broader context of the role of DRG sensory neurons in regulating
antigen trafficking during immunization, these findings suggest
that the nervous system may cooperate with the immune system
to regulate antigen-mediated responses. Maurer and Williams
describe the role of cholinergic signaling in cognition from the
perspective of cholinergic modulation of microglia and astrocyte
function, and the role of this regulation in Alzheimer’s disease
and Parkinson’s disease. The colleagues focus on the cholinergic
modulation of hippocampus-related neuroplasticity and memory
processes and the involvement of the α7 nicotinic acetylcholine
receptor in neuro-immune regulation in this context. Zaghloul
et al. present new data about forebrain cholinergic dysfunction
in parallel with neuroinflammation and peripheral immune
and metabolic dysregulation in mice surviving cecal ligation
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and puncture-induced sepsis. These findings suggest that brain
cholinergic signaling can be further explored as a therapeutic
target in chronic sepsis illness, including cognitive impairment,
functional disabilities, and alarmingly high mortality. Feng et al.
demonstrate that preoperative exercise prevents the cognitive
decline and neuroinflammation and increases the diversity of
the gut microbiome in a model of tibia fracture with internal
fixation surgery in rats with metabolic syndrome. These findings
are of interest for considering exercising, acting as a microbiome
modulator, in alleviating persistent cognitive impairment and
neuroinflammation in postoperative conditions in high risk settings. Yang et al. used a laparotomy model in mice to report on
the role of the blood–brain barrier in postoperative cognitive dysfunction. They found that anesthesia/surgery triggers endothelial
dysfunction in an interleukin-6-dependent and age-associated
manner, with significant cognitive impairments evident in 18-,
but not 9-month-old mice. These data offer additional insights
into the pathogenesis of postoperative complications like delirium and postoperative cognitive d
 ysfunction. Berger et al. report
results from a clinical study designed to evaluate neuroinflammation in patients with intracranial surgery receiving anesthetic
maintenance with propofol or isoflurane. They found significant
increases in cerebrospinal fluid (CSF) cytokine levels 24 h after
surgery (as compared with levels before surgery), in parallel with
increased CSF levels of tau, a neural injury biomarker, but no significant differences in terms of the anesthetic used. These results
suggest that postoperative neuroinflammation in two anesthesia
regimens may have a role in neural injury following intracranial
surgery. Zhang et al. describe the neuroprotective effects of an
annexin A1-derived small peptide on postoperative inflammation and cognitive function after cardiac surgery in rats. They
report significant attenuation of microglial activation, cell death
markers, and NF-κB activation after cardiopulmonary bypass
with deep hypothermic circulatory arrest and, in vitro, using
oxygen-glucose deprivation. These results provide evidence for
the use of novel resolution agonists to treat inflammatory conditions in the perioperative space. Whittington et al. review the role
of inflammation and specialized pro-resolving lipid mediators in
neurological conditions and Alzheimer’s disease. Resolution of
inflammation is well appreciated as an active process regulated by
specialized pro-resolving lipid mediators derived from omega-3
fatty acids. The authors discuss on both preclinical and clinical
evidence supporting the hypothesis that Alzheimer’s disease is a
neurodegenerative disorder where failed resolution contributes
to the disease process. Huh et al. outline the role of bone marrow
stem cells or bone marrow stromal cells (BMSCs) in modulating chronic pain by acting in a paracrine fashion on peripheral
and CNS sites to regulate inflammation. The authors review the
mechanisms of substantial anti-nociceptive efficacy of BMSCs
in preclinical and clinical settings and suggest possibilities for
their use in the management of chronic pain. Pittaluga reviews
the brain functional cross-talk between CCL5 (RANTES),
released from glial cells and glutamate, the main excitatory
neurotransmitter in the brain, in physiological and pathological
conditions. She focuses on preclinical data demonstrating the
role of CCL5 as a modulator of glutamatergic transmission in
health and in demyelinating diseases with relevance to the onset
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of psychiatric symptoms and the progression of inflammation
and demyelination.
Overall, the content of this research topic reflects the significant growth and advances in the field of neuro-immune interactions. It contributes to improved mechanistic understanding,
which is interrelated with evaluating both pharmacological and
bioelectronic approaches to modulate neural circuitry for therapeutic benefit preclinically and in human clinical trials. Further
characterization of neural circuits and signaling mechanisms will
be instrumental to inform the development of safer and more
efficient therapeutic approaches for diseases characterized by dysregulated immune responses, autoimmunity, and inflammation.

Both authors wrote and approved the manuscript.
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